Pharma Pulse 10/29/24: Strengthening Regulatory Framework for Compounded Medications, Cancer Disparities in Rural Areas & more

Strengthening Regulatory Framework for Compounded Medications

Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding explain how the regulatory framework for compounded medications can be further strengthened to ensure quality and safety, while still maintaining flexibility to address patient needs.

Cancer Disparities in Rural Areas: The Impact of Social Determinants of Health and Access Challenges

In a Pharmacy Times interview, Nathan Vanderford, PhD, MBA, Associate Professor of Toxicology and Cancer Biology in the College of Medicine at the University of Kentucky, will discuss cancer disparities and social determinants of health experienced by patients with cancer in rural communities, using his home state of Kentucky as a case study. He sheds light on the various factors, such as limited institutions and resources, that prevent health care professionals from providing the care that many patients need.

It’s Time to Ban Pharmaceutical Advertising

There are too many drug ads on social media to ever regulate them properly, and ads drive up prescription costs.

Parabilis Medicines™ – Formerly FogPharma – Announces New Company Name and Unveils AI- and Physics-Based Discovery Platform

Parabilis Medicines™ (formerly FogPharma), announced a corporate name change. The company’s new name, Parabilis (pronounced puh-RAH-buh-liss), draws on Greek and Latin etymologies to mean both ‘beyond what’s possible’ and ‘obtainable,’ reflecting the company’s drive to expand what is therapeutically possible for the treatment of serious diseases, and its commitment to ensuring its medicines reach and benefit patients globally.

Elena O. on LinkedIn

In the latest episode of the Pharmaceutical Commerce Magazine podcast, Intelliguard® Chief Product Officer, Rob Sobie, shares invaluable insights into the current landscape of the pharmaceutical supply chain.

🔍 Key Challenges Facing Hospitals: Rob discusses the pressing issues hospitals are grappling with today, from inventory management to ensuring patient safety.

🚨 The Failing Drug Supply Chain: He highlights his concerns about the drug supply chain, emphasizing areas that need urgent attention to enhance reliability and efficiency.

💡 RFID Technology Successes: Rob also shines a light on the successful implementation of RFID technology, illustrating how it's revolutionizing tracking and inventory processes within healthcare facilities.

📜 Drug Supply Chain Security Act Overview: Rob provides a high-level overview of the Drug Supply Chain Security Act and shares his thoughts on the recent FDA exemptions, offering a critical perspective on their implications for the industry.

Listen to the full podcast here: https://hubs.ly/Q02VVHxn0

#MedicationManagement #RFID #MedicationSupplyChain

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs